Advertisement
Australia markets closed
  • ALL ORDS

    7,837.40
    -100.10 (-1.26%)
     
  • ASX 200

    7,575.90
    -107.10 (-1.39%)
     
  • AUD/USD

    0.6535
    +0.0012 (+0.18%)
     
  • OIL

    83.99
    +0.42 (+0.50%)
     
  • GOLD

    2,362.30
    +19.80 (+0.85%)
     
  • Bitcoin AUD

    98,638.46
    +1,121.10 (+1.15%)
     
  • CMC Crypto 200

    1,390.16
    -6.37 (-0.46%)
     
  • AUD/EUR

    0.6087
    +0.0014 (+0.23%)
     
  • AUD/NZD

    1.0978
    +0.0021 (+0.19%)
     
  • NZX 50

    11,805.09
    -141.34 (-1.18%)
     
  • NASDAQ

    17,430.50
    -96.30 (-0.55%)
     
  • FTSE

    8,116.55
    +37.69 (+0.47%)
     
  • Dow Jones

    38,085.80
    -375.12 (-0.98%)
     
  • DAX

    18,050.03
    +132.75 (+0.74%)
     
  • Hang Seng

    17,651.15
    +366.61 (+2.12%)
     
  • NIKKEI 225

    37,934.76
    +306.28 (+0.81%)
     

Xerox CEO Visentin Dies After Ongoing Illness

(Bloomberg) -- Xerox Holding Corp. Chief Executive Officer John Visentin died Tuesday after complications from an ongoing illness, the company announced.

Most Read from Bloomberg

“Since joining the company in May 2018, John drove Xerox forward,” Chairman James Nelson said in a statement announcing Visentin’s death. “John’s drive, energy and commitment to the business and its customers, partners and employees will be greatly missed.”

ADVERTISEMENT

Before joining Xerox, Visentin, 59, worked at a variety of tech companies, including International Business Machines Corp. and Hewlett-Packard Co.

Steve Bandrowczak, Xerox president and chief operations officer, will serve as interim CEO, the company said.

Visentin’s tenure was marked by an unsuccessful hostile takeover bid in 2020 for HP Inc., the computer and printer maker. Xerox, a pioneer in photocopying, argued the combination would help modernize the companies in the face of falling demand for printed documents. Xerox has been buffeted by declining revenue the past four years.

(Updates with Visentin’s age in the third paragraph)

Most Read from Bloomberg Businessweek

©2022 Bloomberg L.P.